Form D · Other Technology

VistaPath Biosystems, Inc.

Cambridge, MA · CIK 0001782343

Offering snapshot reported Jul 7, 2023 · SEC filing

Reported sold
$4.44M
Offering amount: $5.66M
Investors reported
5
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 22, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 7, 2023Initial$4,442,495No comparison5SEC filing
Jan 20, 2023Initial$1,000,000No comparison1SEC filing
Jun 21, 2022Amendment$7,416,436$2,099,996vs Feb 9, 202235SEC filing
Feb 9, 2022Initial$5,316,440No comparison30SEC filing
May 20, 2021Initial$100,000No comparison4SEC filing
Sep 23, 2020Amendment$470,000$300,000vs Sep 11, 20209SEC filing
Sep 11, 2020Initial$170,000No comparison6SEC filing
Jul 11, 2019Initial$225,000No comparison4SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-486143

Source: Form D, filed Jul 7, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Burley Benjamin Director, Executive
Benjamin Burley Director, Executive
Timothy Spong Director, Executive
Spong Timothy Director, Executive

Issuer details

Industry: Other Technology (See others in industry)

Address:
1166 Massachusetts Ave
Cambridge, MA, 02139